Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091271 · ClinicalTrials.gov registry record
Screening Protocol to Evaluate Volunteers for NIA Approved Studies
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 5,000
- Enrollment target
NCT02091271: Completed study, sponsored by National Institute on Aging (NIA).
NCT02091271 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 5,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091271 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
The National Institute on Aging (NIA) Intramural Research Program (IRP) has a number ofiRB approved research studies involving human subjects, both normal volunteers and patients. As a means of identifying interested volunteers and other participants in the research process, this screening mechanism is established to identif'y potential eligible participants for NlA protocols. To participate, volunteers/patients must meet the specific requirements of at least one of the available NlA research studies; this protocol serves as a first step for admitting volunteers/patients to an appropriate approved protocol and creating a contact database for approved NlA studies. This protocol will facilitate their recruitment into NIA approved studies and provide NlA staff the opportunity to examine subjects where diagnostic observations can be documented and evaluated for research potential.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2003-02-28 |
| Est. Completion | 2020-03-11 |
What the finished NCT02091271 record still lists
NCT02091271 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02091271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02091271 about?
NCT02091271 is a clinical study titled "Screening Protocol to Evaluate Volunteers for NIA Approved Studies". The National Institute on Aging (NIA) Intramural Research Program (IRP) has a number ofiRB approved research studies involving human subjects, both normal volunteers and patients. As a means of identifying interested volunteers and other participants in the research process, this screening mechanism...
What is the current status of trial NCT02091271?
This trial is currently completed. The enrollment target is 5,000 participants. The study started on 2003-02-28. Estimated completion is 2020-03-11.
Who is sponsoring clinical trial NCT02091271?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI